This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Feb 15;19(4):1233-4.

doi: 10.1200/JCO.2001.19.4.1233.

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

B Vikram

PMID: 11181692
DOI: 10.1200/JCO.2001.19.4.1233

Comment

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

B Vikram. J Clin Oncol. 2001.

. 2001 Feb 15;19(4):1233-4.

doi: 10.1200/JCO.2001.19.4.1233.

Author

B Vikram

PMID: 11181692
DOI: 10.1200/JCO.2001.19.4.1233

No abstract available

PubMed Disclaimer

Comment on

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R. Brizel DM, et al. J Clin Oncol. 2000 Oct 1;18(19):3339-45. doi: 10.1200/JCO.2000.18.19.3339. J Clin Oncol. 2000. PMID: 11013273 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information